Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer

Pharmaceutical Research(2022)10.1007/s11095-022-03434-4Source: DataRank Database

Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer is a research paper published in Pharmaceutical Research (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.36)OA: hybridTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Tamara Minko ORCID,Simav Gildiz

Live enrichment

PubMed:36376606 PMC:PMC9663189 OpenAlex:https://openalex.org/W4308987289

National Institutes of Health

Grant: R01 CA269513

National Institutes of Health

Grant: R01 CA238871

National Institutes of Health

Grant: 5R01CA238871-03

Bionanotechnology approach for treatment of lung cancer

National Institutes of Health

Grant: 5R01CA269513-04

Nanotechnology-based personalized treatment of metastatic ovarian cancer

FWCI

1.36

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s11095-022-03434-4.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s11095-022-03434-4.pdf

publisherhttps://link.springer.com/article/10.1007/s11095-022-03434-4/fulltext.html

journalhttps://doi.org/10.1007/s11095-022-03434-4

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36376606

Fields of Study

Immunotherapy and Immune ResponsesRNA Interference and Gene DeliveryAnimal Virus Infections Studies03 medical and health sciences0302 clinical medicineFemaleHumansNucleic Acid-Based VaccinesProspective StudiesNanotechnologyVaccinesCancer VaccinesOvarian NeoplasmsNanoparticles

MeSH Terms

Nucleic Acid-Based VaccinesFemaleHumansOvarian NeoplasmsProspective StudiesVaccinesCancer VaccinesNanotechnologyNanoparticles

Keywords

Ovarian cancerClinical trialCancerMedicineFood and drug administrationNucleic acidPharmacologyBiologyInternal medicinemRNAVaccineOvarianNanoparticlesOvarian NeoplasmsVaccinesHumansNanotechnologyFemaleReview ArticleProspective StudiesCancer VaccinesNucleic Acid-Based Vaccines

Sustainable Development Goals

SDG 3: 3. Good health